Category: Kinetic Concepts Inc.Syndicate content

Failure of Medtronic's Symplicity-3 trial doesn't mean the end of renal denervation for hypertension | Medtech Wall Street news for the week of September 1, 2014

September 4, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Renal denervation isn't dead, despite Medtronic trial's failure; Baxter says HQ will stay in Illinois, stays coy on Boston plans; Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

September 3, 2014 by Brad Perriello

The private equity owners of sister companies Kinetic Concepts Inc., Systagenix and LifeCell are combining them into a single entity called Acelity.

Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

The private equity owners of a trio of wound care and regenerative medicine companies said today that they're merging Kinetic Concepts Inc., Systagenix and LifeCell into a single entity called Acelity.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

KCI settles Wake Forest wound care patent spat for $280M

July 1, 2014 by Brad Perriello

Kinetic Concepts Inc. agrees to a $280-million settlement of its long-running patent infringement war with Wake Forest University over negative-pressure wound therapy technology.

KCI settles Wake Forest wound care patent spat for $280M

UPDATED July 1, 2014, with comment from KCI.

Kinetic Concepts Inc. said it agreed to pay $280 million to settle a patent infringement lawsuit with Wake Forest University, putting their long-running war over negative-pressure wound therapy to rest.

CeQur names medtech veteran as new CEO | Medtech personnel moves for the week of Apr. 14, 2014

April 16, 2014 by MassDevice

Here's a look at some of the top personnel stories for medical device companies this week.

CeQur gets new CEO from Becton Dickinson | Personnel Moves

April 11, 2014 by Arezu Sarvestani

fired/hired

Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.

CeQur gets new CEO from Becton Dickinson | Personnel Moves

April 11, 2014 by Arezu Sarvestani

CeQur gives Douglas Lawrence the keys to the corner office, taking him from the insulin injection business at Becton Dickinson.

fired/hired

Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.

Lawrence has spent more than 25 years in the medical device industry, most recently as vice president of the insulin injection business at Becton, Dickinson's (NYSE:BDX) diabetes arm.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4

March 10, 2014 by Arezu Sarvestani

The medtech giant formed by the merger of Kinetic Concepts, LifeCell Corp. and Systagenix swings to the red in Q4 amid a near 7% boost in sales.

Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4

The newly formed medtech alliance comprised of Kinetic Concepts, LifeCell and Systagenix posted collective figures that put the group in the red for Q4, a recent SEC filing shows.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp